| Susan Dale Rogers, CRNA | |
|
480 Hutchinson Dr, Carthage, MS 39051-7588 | |
| (601) 416-0652 | |
| Not Available |
| Full Name | Susan Dale Rogers |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 22 Years |
| Location | 480 Hutchinson Dr, Carthage, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548221427 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rush Foundation Hospital | Meridian, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Foundation Inc | 9234043712 | 125 |
News Archive
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
Quality Physicians Insurance Program, a risk purchasing group providing professional liability insurance to physicians in Maryland, Washington DC and Virginia, recently celebrated the company's 1st anniversary.
Abraxis BioScience, Inc., a fully integrated biotechnology company, welcomes the announcement today that following a full submission, the Scottish Medicines Consortium (SMC) has accepted ABRAXANE® (paclitaxel albumin) for restricted use within the National Health Service (NHS) for Scotland in patients who would otherwise receive docetaxel or 3-weekly solvent-based paclitaxel as second-line treatment for metastatic breast cancer.
Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier - a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.
Heart attack rates have spiked in Greece since the start of the country's financial crisis, especially among women and residents older than 45, according to a study of patient records being presented at the American College of Cardiology's 62nd Annual Scientific Session.
› Verified 4 days ago
| Entity Name | Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609820539 PECOS PAC ID: 9234043712 Enrollment ID: O20031118000855 |
News Archive
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
Quality Physicians Insurance Program, a risk purchasing group providing professional liability insurance to physicians in Maryland, Washington DC and Virginia, recently celebrated the company's 1st anniversary.
Abraxis BioScience, Inc., a fully integrated biotechnology company, welcomes the announcement today that following a full submission, the Scottish Medicines Consortium (SMC) has accepted ABRAXANE® (paclitaxel albumin) for restricted use within the National Health Service (NHS) for Scotland in patients who would otherwise receive docetaxel or 3-weekly solvent-based paclitaxel as second-line treatment for metastatic breast cancer.
Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier - a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.
Heart attack rates have spiked in Greece since the start of the country's financial crisis, especially among women and residents older than 45, according to a study of patient records being presented at the American College of Cardiology's 62nd Annual Scientific Session.
› Verified 4 days ago
| Entity Name | Meridian Anesthesiology Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639181019 PECOS PAC ID: 1759345192 Enrollment ID: O20041116000675 |
News Archive
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
Quality Physicians Insurance Program, a risk purchasing group providing professional liability insurance to physicians in Maryland, Washington DC and Virginia, recently celebrated the company's 1st anniversary.
Abraxis BioScience, Inc., a fully integrated biotechnology company, welcomes the announcement today that following a full submission, the Scottish Medicines Consortium (SMC) has accepted ABRAXANE® (paclitaxel albumin) for restricted use within the National Health Service (NHS) for Scotland in patients who would otherwise receive docetaxel or 3-weekly solvent-based paclitaxel as second-line treatment for metastatic breast cancer.
Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier - a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.
Heart attack rates have spiked in Greece since the start of the country's financial crisis, especially among women and residents older than 45, according to a study of patient records being presented at the American College of Cardiology's 62nd Annual Scientific Session.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Dale Rogers, CRNA 480 Hutchinson Dr, Carthage, MS 39051-7588 Ph: (601) 416-0652 | Susan Dale Rogers, CRNA 480 Hutchinson Dr, Carthage, MS 39051-7588 Ph: (601) 416-0652 |
News Archive
GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.
Quality Physicians Insurance Program, a risk purchasing group providing professional liability insurance to physicians in Maryland, Washington DC and Virginia, recently celebrated the company's 1st anniversary.
Abraxis BioScience, Inc., a fully integrated biotechnology company, welcomes the announcement today that following a full submission, the Scottish Medicines Consortium (SMC) has accepted ABRAXANE® (paclitaxel albumin) for restricted use within the National Health Service (NHS) for Scotland in patients who would otherwise receive docetaxel or 3-weekly solvent-based paclitaxel as second-line treatment for metastatic breast cancer.
Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier - a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.
Heart attack rates have spiked in Greece since the start of the country's financial crisis, especially among women and residents older than 45, according to a study of patient records being presented at the American College of Cardiology's 62nd Annual Scientific Session.
› Verified 4 days ago